Medige Scottsdale is a purpose-driven center exclusively providing TULSA-PRO services. Utilizing the latest 3-Tesla MRI technology, Medige Scottsdale’s TULSA-PRO innovations have led to reduced treatment times, durable outcomes and minimal side effects. As a urologist-led center, Medige Scottsdale specializes in an end-to-end solution for prostate cancer. Medige Scottsdale’s signature approach is a collaborative TULSA-PRO treatment plan that values patient input, including concern regarding loss of bodily functions and dignity, to achieve the best outcome.
Medige Scottsdale’s experienced team welcomes patients locally, regionally, nationally and internationally. Surrounded by comfortable resorts and amenities, Medige Scottsdale strives for a holistic cure to prostate cancer with integrity, respect and compassion.
Dr. Y. Mark Hong is among the most experienced TULSA-PRO surgeons in the United States and the first to perform TULSA-PRO in Arizona. A summa cum laude graduate of Rice University, Dr. Hong attended Stanford University School of Medicine and completed urological surgery residency at Brigham and Women’s Hospital and Harvard Medical School. During fellowship at George Washington University, Dr. Hong researched improvements in robotic prostatectomy technique to improve incontinence and sexual dysfunction.
Despite advances in robotic surgery, Dr. Hong recognized ongoing challenges to curing prostate cancer without collateral damage. Having performed TULSA-PRO since 2021, Dr. Hong believes curing prostate cancer without harmful side effects is not only possible but likely with careful TULSA-PRO planning and execution. Having completed a fellowship in Integrative Medicine with Dr. Andrew Weil at University of Arizona, Dr. Hong is founding member of Integrative Urology, a practice rooted in the belief the body has a natural ability to heal. Dr. Hong has been featured on WebMD, ABC, NBC, Fox, CBS news affiliates, Today Show, radio, BuzzFeed and numerous media outlets.
Get the latest tips for all ages and stages. Subscribe to our newsletter.